Atlas Antibodies Anti-PRSS54 Antibody

상품 한눈에 보기

Human PRSS54 단백질을 표적으로 하는 Rabbit Polyclonal Antibody로, IHC 및 WB 검증에 적합합니다. Orthogonal 및 Recombinant Expression Validation을 통해 높은 신뢰성 확보. Affinity purification으로 높은 특이성과 재현성 제공.

카탈로그번호: HPA041549-xxx (2개 옵션)
브랜드: Atlas Antibodies
카테고리: Polyclonal Antibodies
판매단위: 100ul, 25ul

#Antibodies #Atlas Antibodies

카탈로그

2개 옵션

회원가입 없이 바로 구매하세요

가입하지 않아도 비회원가로 구매하실 수 있습니다.

카탈로그 번호 · 상품 설명출고판매가담기

Atlas Antibodies HPA041549-100 Anti-PRSS54 Antibody, protease, serine, 54 100ul판매 단위 100ul ·

재고 확인 필요재고 확인 필요

728,000원VAT 포함 800,800원

Atlas Antibodies HPA041549-25 Anti-PRSS54 Antibody, protease, serine, 54 25ul판매 단위 25ul ·

재고 확인 필요재고 확인 필요

528,000원VAT 포함 580,800원

재고문의·견적요청 옵션은 실시간 상담으로 납기를 확인해 드립니다 · 연구비 카드 결제 가능

Atlas Antibodies · Atlas Antibodies Anti-PRSS54 Antibody

Anti-PRSS54 Antibody

Target: protease, serine, 54
Supplier: Atlas Antibodies

Recommended Applications

IHC (Orthogonal Validation): Orthogonal validation of protein expression using IHC by comparison to RNA-seq data of corresponding target in high and low expression tissues.
WB (Recombinant Expression Validation): Recombinant expression validation in WB using target protein overexpression.

Product Description

Polyclonal Antibody against Human PRSS54

Alternative Gene Names

CT67, FLJ25339, KLKBL4

Open Datasheet

Target Information

항목	내용
Target Protein	protease, serine, 54
Target Gene	PRSS54
Antigen Sequence	Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence
Verified Species Reactivity	Human
Interspecies Information	Mouse ENSMUSG00000048400 (68%), Rat ENSRNOG00000023092 (64%)

Antigen Sequence:
VFYGPDPKEGLVSSMEFPWVVSLQDSQYTHLAFGCILSEFWVLSIASAIQNRKDIVVIVGISNMDPSKIAHTEYPVNTIIIHEDFDNNSMSN

Antibody Characteristics

항목	내용
Clonality	Polyclonal
Isotype	IgG
Host	Rabbit
Purification Method	Affinity purified using the PrEST antigen as affinity ligand
Buffer	40% glycerol and PBS (pH 7.2). 0.02% sodium azide added as preservative. Material Safety Data Sheet
Notes	Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user.